Entreprenuer, Partner at Ortiz & Lopez, PLLC, Co-Founder at EV Charging Startup.
Luis M. Ortiz is a Registered Patent Attorney, has an AV® Preeminent Rating from Martindale-Hubble, is a Certified Licensing Professional (CLP®), and has over thirty years experience counseling and representing clients in intellectual property matters including: litigation, licensing, patent and trademark prosecution, patent/trademark portfolio development strategies, negotiating contracts and intellectual property-related agreements, and mediation of IP disputes.
Luis Ortiz’ engineering, business and legal expertise is applied to often complicated intellectual property issues on behalf of his clients. His clients have included fortune 500 companies, medium-sized companies, startups, federal research laboratories, and universities. Luis has held leadership roles in both private an public legal organizations.
Luis is licensed to practice law before Texas State Courts, New Mexico State Courts, Federal District Courts for the Eastern District of Texas and New Mexico, the Federal Court of Claims, the Court of Appeals for the Federal Circuit, and as a “registered patent attorney” before the U.S. Patent and Trademark Office.
Luis is also a retired U.S. Air Force Reserve Lieutenant Colonel, Judge Advocate General’s Corps, after thirty years of service. Luis handled issues associated with government contracting, FOIA requests, data rights and intellectual property for the U.S. Air Force Material Command (AFMC). Luis has held Top Secret clearances during his work on behalf of the federal government.
Luis co-founded the law firm, Ortiz & Lopez, PLLC (“OL PATENTS”), with locations in Albuquerque, New Mexico, Dallas, Texas, El Paso, Texas and Las Vegas, Nevada. The firm specializes in intellectual property protection, IP litigation and licensing and serves clients throughout the United States and internationally.
Patent №: 11950923 (April 9, 2024) – Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals. The system monitors mammal conditions, reports changes, and provides neurocode-based treatment. An implantable controller monitors and communicates wirelessly with external computers for treatment administration based on condition changes. Treatment can alter biological function or induce cancer cell death. External computers include mobile devices, resident treatment pods, and treatment servers.
Wang received the B.S. and M.S. degrees in electronic engineering from Tsinghua University, P. R. China in 1992 and 1994, respectively.
She received her Ph.D. degree in electrical engineering from the University of Southern California in 2001.
Michelle joined Photobit Corp. in 1998 working on automotive sensors and invented a dual sensitivity pixel for high dynamic range imaging.
In 2001, Yibing was with Centellax Inc. working on 40Gbps optical transceiver and SERDES designs. Since 2002, she joined Forza Silicon Corp. leading and participating in medical, automotive and cinematography sensor designs.
In 2008, Wand joined Hynix Semiconductor America leading product design effort on mobile image sensors.
In 2011, she joined Samsung Semiconductor, Inc. working on innovative solutions for advanced image sensors, 3D sensors and optical interconnects.
Patent №: 11954574 (April 9, 2024) – Neural processor. The first tile includes a first weight register, a second weight register, an activations buffer, and first and second multipliers. The activations buffer has two queues connected to the multipliers. In the first state, the first multiplier multiplies a weight by an activation from the first queue, while in the second state, it multiplies the weight by an activation from the second register of the first queue.
Building clinical evidence and innovation in medical devices.
Stuart earned a Bachelor of Science (B.S.) degree in Biomedical Engineering from Washington University in St. Louis, which they attended from 2000 to 2005.
Stuart further pursued their education in the same field at the same institution and obtained a Master of Science (M.S.) degree from Washington University in St. Louis from 2003 to 2005.
Patent №: 11951319 (April 9, 2024) – Systems and methods for applying anti-tachycardia pacing using subcutaneous implantable cardioverter-defibrillators. The disclosure offers systems and methods for applying anti-tachycardia pacing (ATP) via subcutaneous implantable cardioverter-defibrillators (SICDs). An SICD implanted in a subject comprises a case with a controller and at least one conductive lead containing multiple coil electrodes. The SICD, controlled by the controller, delivers ATP to the subject using the conductive lead.
R&D Sr. Fellow, Sr. Manager at Honeywell UOP
Chunqing received Honeywell Innovation Initiators Award in 2022, Honeywell UOP Stine Star Award in 2019, the ACS Women Chemists Committee Rising Star Award in 2015, and the Honeywell Excellence in Innovation Award in 2010.
Patent №: 11955678 (April 9, 2024) – Method to improved redox flow battery performance. This involves controlling pre-charging to enable uniform and ductile metal plating on the negative electrode, such as Fe(O). Pre-charging control can be coupled with increasing metal ion concentration compared to existing systems. This can be done by maintaining equal metal ion concentration in both negative and positive electrolytes or by increasing metal ion concentration in the negative electrolyte to surpass that of the positive electrolyte.
Welcome to June 10, 2025. This week, we aim to celebrate the centurion patentors who have reached noteworthy milestones in…
Welcome to June 3, 2025. This week, we aim to celebrate the centurion patentors who have reached noteworthy milestones in…
Welcome to May 27, 2025. This week, we aim to celebrate the centurion patentors who have reached noteworthy milestones in…
Welcome to May 20, 2025. This week, we aim to celebrate the centurion patentors who have reached noteworthy milestones in…
Welcome to May 13, 2025. This week, we aim to celebrate the centurion patentors who have reached noteworthy milestones in…
Welcome to May 6, 2025. This week, we aim to celebrate the centurion patentors who have reached noteworthy milestones in…